|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Oct 31, 2022
|
Q2 FY2022
As of Jul 31, 2022
|
Q1 FY2022
As of Apr 30, 2022
|
Q4 FY2021
As of Jan 31, 2022
|
Q3 FY2021
As of Oct 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||
| Cash | ||||||||||
| Accounts receivable, net | ||||||||||
| Inventories, net | ||||||||||
| Other receivables | ||||||||||
| Nonrelated Party | ||||||||||
| Related Party | ||||||||||
| Total other receivables | ||||||||||
| Prepaid expenses and other current assets | ||||||||||
| Forward purchase receivables | ||||||||||
| Current assets of discontinued operations | ||||||||||
| Total Current Assets | ||||||||||
| PROPERTY AND EQUIPMENT, NET | ||||||||||
| TOTAL PROPERTY AND EQUIPMENT, NET | ||||||||||
| OTHER ASSETS | ||||||||||
| Prepaid expenses - non-current | ||||||||||
| Intangible assets, net | ||||||||||
| Goodwill | ||||||||||
| Operating lease right-of-use assets | ||||||||||
| Finance lease right-of-use assets | ||||||||||
| Total Other Assets | ||||||||||
| Total Assets | ||||||||||
| LIABILITIES AND SHAREHOLDERS’ DEFICIT | ||||||||||
| Accrued offering costs and expenses | ||||||||||
| CURRENT LIABILITIES | ||||||||||
| Short term loans - bank and private lender | ||||||||||
| Short term loans - related parties | ||||||||||
| Short term loans | ||||||||||
| Related Party | ||||||||||
| Private Lenders | ||||||||||
| Promissory note | ||||||||||
| Convertible notes | ||||||||||
| Nonrelated Party | ||||||||||
| Related Party | ||||||||||
| Total convertible notes | ||||||||||
| Convertible notes - related parties | ||||||||||
| Accounts payable | ||||||||||
| Other payables and accrued liabilities | ||||||||||
| Other payables - related parties | ||||||||||
| Customer deposits | ||||||||||
| Warrants liabilities | ||||||||||
| Operating lease liabilities | ||||||||||
| Finance lease liabilities | ||||||||||
| Prepaid forward purchase liabilities | ||||||||||
| Taxes payable | ||||||||||
| Current liabilities of discontinued operations | ||||||||||
| Total Current Liabilities | ||||||||||
| OTHER LIABILITIES | ||||||||||
| Deferred tax liabilities | ||||||||||
| Operating lease liabilities - non-current | ||||||||||
| Finance lease liabilities - non-current | ||||||||||
| Total Other Liabilities | ||||||||||
| Total Liabilities | ||||||||||
| SHAREHOLDERS’ DEFICIT | ||||||||||
| Ordinary shares, no par value, unlimited shares authorized, 1,890,375 shares and 1,857,653 shares issued and outstanding as of December 31, 2025 and 2024, respectively | ||||||||||
| Accumulated deficit | ||||||||||
| Accumulated other comprehensive loss | ||||||||||
| Total Euda Health Holdings Limited Shareholders’ Deficit | ||||||||||
| Noncontrolling interests | ||||||||||
| Total Shareholders’ Deficit | ||||||||||
| Total Liabilities and Shareholders’ Deficit | ||||||||||
Loading...